Japanese Officials Approve Epidiolex For Clinical Trials
Cannabis Law Report
MARCH 30, 2019
The trials, to be tightly controlled in a hospital environment, are exempted from Japan’s Cannabis Control Act, which bans cannabis compounds generally. Epidiolex was crafted as a treatment for two forms of childhood epilepsy. Japanese officials approve Epidiolex for clinical trials.